Page last updated: 2024-08-17

quinoxalines and apnea

quinoxalines has been researched along with apnea in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borday, V; Denavit-SaubiƩ, M; Foutz, AS; Nordholm, L1
Dretchen, KL; Gillis, RA; Hernandez, YM; McManigle, JE; Taveira Da Silva, AM1
Hall, D; Prok, L1
Heimann, K; Hoernchen, H; Merz, U; Peschgens, T; Wenzl, T1
Carley, DW; Isenovic, ER; Radulovacki, M1
Iotova, V; Kiryazov, K; Stefova, M1

Other Studies

6 other study(ies) available for quinoxalines and apnea

ArticleYear
Respiratory effects of glutamate receptor antagonists in neonate and adult mammals.
    European journal of pharmacology, 1998, May-08, Volume: 348, Issue:2-3

    Topics: Age Factors; Animals; Animals, Newborn; Apnea; Cats; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Injections, Subcutaneous; Mice; Plethysmography; Pulmonary Ventilation; Quinoxalines; Receptors, Glutamate; Species Specificity

1998
Respiratory depression produced by intravenously administered NBQX.
    Pharmacology, 1998, Volume: 56, Issue:6

    Topics: Animals; Apnea; Atrial Function; Blood Pressure; Cats; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Heart Rate; Injections, Intravenous; Phrenic Nerve; Quinoxalines; Respiratory Insufficiency; Respiratory Physiological Phenomena; Respiratory System

1998
A 24-day old with episodic lethargy, hypotonia, and apnea: the eyes have it.
    Current opinion in pediatrics, 2003, Volume: 15, Issue:2

    Topics: Adrenergic alpha-Agonists; Apnea; Brimonidine Tartrate; Cataract; Humans; Infant, Newborn; Male; Muscle Hypotonia; Quinoxalines; Sleep Stages

2003
[Depression of respiration via toxic effects on the central nervous system following use of topical brimonidine in an infant with congenital glaucoma].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2007, Volume: 104, Issue:6

    Topics: Antihypertensive Agents; Apnea; Brimonidine Tartrate; Cataract; Female; Glaucoma; Humans; Infant, Newborn; Infant, Premature, Diseases; Neurotoxicity Syndromes; Ophthalmic Solutions; Postoperative Complications; Quinoxalines; Respiratory Insufficiency; Trabeculectomy

2007
Impact of intertrigeminal region AMPA receptor blockade on respiratory responses in rats.
    Respiratory physiology & neurobiology, 2007, Aug-15, Volume: 158, Issue:1

    Topics: Animals; Apnea; Glutamic Acid; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Reflex; Respiratory Mechanics; Serotonin; Trigeminal Nerve; Trigeminal Nuclei; Vagus Nerve

2007
Can ophthalmic drops cause central nervous system depression and cardiogenic shock in infants?
    Pediatric emergency care, 2013, Volume: 29, Issue:11

    Topics: Absorption; Administration, Ophthalmic; Apnea; Bradycardia; Brimonidine Tartrate; Consciousness Disorders; Dose-Response Relationship, Drug; Drug Combinations; Emergencies; Female; Glaucoma; Humans; Hypothermia; Infant; Muscle Hypotonia; Nasal Mucosa; Ophthalmic Solutions; Quinoxalines; Shock, Cardiogenic; Sulfonamides; Thiazines; Timolol

2013